All news

Outstanding shares remain unchanged as Addex (ADXN) issues new shares to its wholly owned subsidiary.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Addex Therapeutics Ltd. (SIX: ADXN and Nasdaq: ADXN) issued 93,000,000 new registered shares to its wholly-owned subsidiary, Addex Pharma S.A., at a nominal value of CHF 0.01 each. This transaction, executed from the company’s capital band, aims to provide future financing flexibility and create treasury shares. While the issued share capital increased, the number of outstanding shares remains unchanged.

Read original source

ADXN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.